[CLSTR]
< Back to situations

[ORGANIZATION]

Novartis

Featured in 62 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [DE] [IT]

Clinical applications and access of CAR-T and myeloma cell/m

21 clusters · 73 sources · last updated

Latest: CAR T-cell therapy shows promise for hairy cell leukemia

CAR-T cell therapy continues to expand its clinical utility across oncology and autoimmune diseases. In oncology, the therapy is transforming treatment for aggressive lymphomas and resistant blood cancers. A significant

[ACTIVE] [BUSINESS] [CH]

Novartis financial performance and guidance updates

2 clusters · 10 sources · last updated

Latest: Novartis raises profit guidance following strong Q3 sales

In the second quarter of 2026, Novartis reported a 1% increase in net sales, driven by priority brands such as Kisqali and Kesimpta. Despite this growth, the company saw a 19% decline in net income and flat core operatin

[ACTIVE] [BUSINESS] [CH] [ES] [US]

Novartis biomedical research and manufacturing expansion

2 clusters · 6 sources · last updated

Latest: Novartis and Sanitas highlight medical innovation and clinical trial expansion

Novartis has initiated several strategic expansions in research and specialized manufacturing. In the United States, the company has broken ground on a 466,000-square-foot biomedical research center in San Diego, Califor

[ACTIVE] [TECHNOLOGY] [DE] [NL] [US]

SAP artificial intelligence development strategy

4 clusters · 35 sources · last updated

Latest: SAP expands AI and automation partnerships with Intel and NVIDIA

SAP CEO Christian Klein has identified artificial intelligence as a historic growth opportunity, focusing on the development of AI agents to create an ‘autonomous enterprise’ through a unified platform. While German mid-

[ACTIVE] [HEALTH] [CN] [NO]

Tea consumption and cardiovascular disease study

2 clusters · 22 sources · last updated

Latest: Research highlights tea consumption and cardiac rehabilitation challenges

A long-term observational study involving nearly 500,000 adults in China has linked regular tea consumption to an 11% lower risk of developing vascular diseases, such as stroke and heart disease. Researchers from Peking

[ACTIVE] [HEALTH] [US] [CH]

Novartis remibrutinib clinical development

2 clusters · 11 sources · last updated

Latest: Novartis remibrutinib reduces multiple sclerosis relapse rates

Novartis is advancing the clinical application of remibrutinib, an oral Bruton tyrosine kinase (BTK) inhibitor, across different medical indications. In October 2026, the US Food and Drug Administration (FDA) approved r

[ACTIVE] [HEALTH] [IT] [BR] [DO]

Italy expands preventive health services and reforms 2026

60 clusters · 318 sources · last updated

Latest: Italy mammography screening reaches record 77% amid regional disparities

Throughout 2026, Italy has expanded its preventive health services through regional initiatives, legislative reforms, and community outreach. Key developments include the extension of mammography screening to women aged

[ACTIVE] [HEALTH] [ES] [EU] [IT]

Ribociclib Natalee study breast cancer results

2 clusters · 8 sources · last updated

Latest: Ribociclib reduces early breast cancer death risk by 20% in 6-year study

Long-term data from the Phase III Natalee study indicates that ribociclib (Kisqali), when combined with hormone therapy, reduces the risk of death by approximately 19% to 20% in patients with early-stage, HR-positive, HE

[ACTIVE] [BUSINESS] [CH] [CN] [US]

Swiss watch and gold export trends

2 clusters · 11 sources · last updated

Latest: Swiss exports see growth in watch and gold sectors

In September 2026, the Swiss watch industry reported an 11.7 percent increase in exports, totaling 2.23 billion francs. This growth follows three consecutive months of expansion, bringing the total for the first nine mon

[QUIET] [TECHNOLOGY] [DE]

Industrial AI integration in manufacturing and logistics

2 clusters · 11 sources · last updated

Latest: IFS launches Industrial AI platform to automate operational tasks

Developments in industrial artificial intelligence have focused on integrating AI platforms with manufacturing and warehouse operations to enhance worker assistance and operational efficiency. In late September 2026, iT

[QUIET] [BUSINESS] [US] [AE] [KR]

Solidigm potential US IPO

2 clusters · 16 sources · last updated

Latest: Isomorphic Labs seeks valuation up to $50 billion

Solidigm, a US-based subsidiary of SK hynix specializing in NAND and enterprise SSDs, is considering an initial public offering (IPO) in the United States as early as 2027. The potential listing could value the company a

[QUIET] [BUSINESS] [DE] [BR] [CH]

Psychological influences on consumer and investor behavior

5 clusters · 9 sources · last updated

Latest: Common risks and mistakes for novice stock market investors

Psychological pressures and cognitive biases significantly influence the decision-making processes of both retail investors and consumers. In financial markets, investors often struggle with emotional decision-making and

[QUIET] [BUSINESS] [CH] [US] [CN]

Pharmaceutical industry drug discovery partnerships

2 clusters · 6 sources · last updated

Latest: Novartis and Sanofi lead major pharmaceutical licensing and alliance expansions

Major pharmaceutical companies are entering large-scale partnerships to advance drug discovery and development through specialized technologies. In late September 2026, Boehringer Ingelheim expanded its collaboration wi

[QUIET] [HEALTH] [DE] [DK] [GR]

Inclisiran efficacy and evolving LDL cholesterol treatments

4 clusters · 12 sources · last updated

Latest: Inclisiran shows 56% reduction in LDL cholesterol in new study

Research into the efficacy of inclisiran, a drug utilizing small interfering RNA (siRNA) technology to inhibit PCSK9 protein production, has demonstrated significant potential in reducing LDL cholesterol. An initial met

Also covered in